CA-125 is an effective marker for patients with external endometriosis and on danazol: case reports

K. Takahashi, Takahashi K, K. Yoshino, Yoshino K, H Nagata, Nagata H, M Kusakari, Kusakari M, Kitao M, M Kitao
Fertility and sterility · 1988 · doi:10.1016/s0015-0282(16)60028-6 · PMID:3164281
case-report OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-02 ⓘ

This case series analyzed serum CA-125 levels over time in four patients with external endometriosis treated with danazol, finding CA-125 useful for predicting relapse.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Serum levels of CA-125 in women with external endometriosis and on danazol were assayed for an extended period, and changes in the CA-125 pattern were analyzed. Whereas the prognosis for the patients in case 1 was good, those for cases 2, 3, and 4 were poor. We propose that the Ca-125 levels should be carefully determined for individual patients, because a relapse can be predicted.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antigens, Neoplasm Danazol Endometriosis Pregnadienes Adult Antigens, Neoplasm Antigens, Tumor-Associated, Carbohydrate Danazol Endometriosis Endometriosis Female Humans Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-25T06:10:54.854274+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine